Mingyu Huo, Ph.D.
- Center for Cancer Research
- National Cancer Institute
Postdoctoral Fellow (Visiting)
RESEARCH SUMMARY
Mingyu earned her Ph.D. in Biomedical Sciences from The Chinese University of Hong Kong. Her current research at Dr. Mitchell Ho’s lab at the National Cancer Institute focuses on engineering allogeneic CAR-T cells using CRISPR/Cas9 technology to enhance cancer immunotherapy. Beyond her scientific endeavors, she enjoys traveling and snowboarding.
Areas of Expertise
Genome Editing
Cell Engineering
CAR-T Immunotherapy